Houston, TX -- (SBWIRE) -- 02/08/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
WidePoint Corporation (NYSE:WYY) added 1.61% and is trading at $0.630. WidePoint Corporation (WidePoint) is a provider of customized technology-based products and solutions to both the government sector and commercial markets. The Company operates in three segments: Communications Management, Cybersecurity Solutions, and Consulting Services and Products.
Can WYY Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Tianyin Pharmaceutical Co, Inc. (NYSE:TPI) is lower 3.80% and is trading at $0.760. Tianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company’s indirect wholly owned subsidiary Chengdu Tianyin Pharmaceutical Co., Ltd. (Chengdu Tianyin), it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in the People’s Republic of China.
How Should Investors Trade TPI After The Recent Volatile Moves? Find Out Here
LRAD Corp (NASDAQ:LRAD) is higher 0.81% and is trading at $1.25. LRAD Corporation is engaged in the design, development and commercialization of directed sound technologies and products. The Company develops and delivers directed acoustic products that beam, focus and control sound over short and long distances.
Is LRAD Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) added 9.80% and is trading at $0.728. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates. The Company is developing drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors (TLRs).
Can IDRA Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
NTS Inc (NYSE:NTS) is lower 0.95% and is trading at $1.04. NTS Inc, formerly Xfone, Inc. is a holding and managing company providing, through its subsidiaries, integrated communications services, which include voice, video and data over its Fiber-To-The-Premise (FTTP) and other networks.
Is NTS Ready To Move Back To New Highs This Year? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)